{"id":11270,"date":"2021-09-04T06:52:36","date_gmt":"2021-09-04T06:52:36","guid":{"rendered":"https:\/\/haberglobal.com.tr\/saglik\/hekimlerden-sinovac-olanlara-uyari-iki-doz-olanlar-risk-altinda-4-ay-sonra-asisiz-olmak-gibi-130470"},"modified":"2021-09-04T06:52:36","modified_gmt":"2021-09-04T06:52:36","slug":"hekimlerden-sinovac-olanlara-uyari-iki-doz-olanlar-risk-altinda-4-ay-sonra-asisiz-olmak-gibi","status":"publish","type":"post","link":"https:\/\/istanbulchannel.net\/index.php\/2021\/09\/04\/hekimlerden-sinovac-olanlara-uyari-iki-doz-olanlar-risk-altinda-4-ay-sonra-asisiz-olmak-gibi\/","title":{"rendered":"Hekimlerden Sinovac olanlara uyar\u0131: \u0130ki doz olanlar risk alt\u0131nda, 4 ay sonra a\u015f\u0131s\u0131z olmak gibi"},"content":{"rendered":"
<\/div>\n
<\/div>\n

Sa\u011fl\u0131k Bakan\u0131 Fahrettin Koca son Bilim Kurulu toplant\u0131s\u0131 sonras\u0131 yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, koronavir\u00fcs\u00fcn neden oldu\u011fu Covid-19 hastal\u0131\u011f\u0131 nedeniyle hastaneye yatan ki\u015filerin y\u00fczde 90\u2019\u0131n\u0131n “tam a\u015f\u0131l\u0131 olmayanlar” oldu\u011funu s\u00f6yledi. BBC T\u00fcrk\u00e7e\u2019ye konu\u015fan uzman hekimler de, \u015fu anda hastanelerin yo\u011fun bak\u0131m birimlerinde Covid-19 tedavisi g\u00f6renlerin genellikle ya a\u015f\u0131s\u0131z ki\u015filerden ya da \u00e7ift doz Sinovac a\u015f\u0131s\u0131 \u00fczerinden 4 ay ge\u00e7mi\u015f ve 3. doz a\u015f\u0131s\u0131n\u0131 yapt\u0131rmam\u0131\u015f ki\u015filerden olu\u015ftu\u011funu s\u00f6yl\u00fcyor.<\/p>\n

Bakan Fahrettin Koca a\u00e7\u0131klamas\u0131nda, Covid-19 sonucu hayat\u0131n\u0131 kaybedenlerin y\u00fczde 90\u2019\u0131n\u0131n ya hi\u00e7 a\u015f\u0131 olmam\u0131\u015f ya da a\u015f\u0131lar\u0131 eksik ki\u015filer oldu\u011funu s\u00f6yledi. Koca ayr\u0131ca \u015fu anda aktif vakalar\u0131n y\u00fczde 81\u2019ini tam a\u015f\u0131l\u0131 olmayanlar\u0131n olu\u015fturdu\u011funu belirtti.<\/p>\n

Tek doz a\u015f\u0131n\u0131n koruyuculuk a\u00e7\u0131s\u0131ndan yeterli olmad\u0131\u011f\u0131n\u0131 s\u00f6yleyen Koca, vakalar\u0131n \u015fu anda en yo\u011fun olarak 15-45 ya\u015f grubu aras\u0131nda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc aktard\u0131.<\/p>\n

Bakan Koca ayr\u0131ca 2 doz Sinovac a\u015f\u0131s\u0131n\u0131n \u00fczerinden 3 ay ge\u00e7enlerin, 3. doz a\u015f\u0131 olmas\u0131 gerekti\u011fini vurgulad\u0131:<\/p>\n

“\u00d6zellikle elimizdeki veriler \u00fc\u00e7\u00fcnc\u00fc aydan sonra bu koruyuculu\u011fun azald\u0131\u011f\u0131n\u0131, ya\u015fl\u0131 grupta ek olarak daha da d\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc g\u00f6steriyor. Yani 2 doz inaktif a\u015f\u0131s\u0131 yapt\u0131rm\u0131\u015f ki\u015fi rahat hareket etmemeli, 3 ay sonra yeni a\u015f\u0131s\u0131n\u0131 yapt\u0131rmal\u0131d\u0131r.”<\/p>\n

Koca, mRNA a\u015f\u0131s\u0131 i\u00e7in ise “\u0130ki a\u015f\u0131n\u0131n mutlak yap\u0131lmas\u0131 gerekti\u011fini biliyoruz. mRNA a\u015f\u0131s\u0131 i\u00e7in hat\u0131rlatma dozu i\u00e7in yapt\u0131\u011f\u0131m\u0131z \u00e7al\u0131\u015fmalarda koruyuculu\u011funun devam etti\u011fini biliyoruz. 8 ay sonra riskli grupta daha \u00f6nemli oldu\u011funu biliyoruz” dedi.<\/p>\n

UZMAN HEK\u0130MLER NE D\u0130YOR?<\/strong><\/p>\n

BBC T\u00fcrk\u00e7e\u2019ye konu\u015fan uzman hekimler de, \u015fu anda yo\u011fun bak\u0131mlarda Covid-19 tedavisi g\u00f6rmekte olan hastalar\u0131n genellikle ya a\u015f\u0131s\u0131z ki\u015filerden ya da \u00e7ift doz Sinovac a\u015f\u0131s\u0131 \u00fczerinden 4 ay ge\u00e7mi\u015f ve 3. doz a\u015f\u0131s\u0131n\u0131 yapt\u0131rmam\u0131\u015f ki\u015filerden olu\u015ftu\u011funu s\u00f6yl\u00fcyor.<\/p>\n

Ankara \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesi\u2019nden Prof. Dr. Necmettin \u00dcnal, hastanenin yo\u011fun bak\u0131m\u0131nda Covid-19 tedavisi g\u00f6rmekte olan 47 hastan\u0131n yar\u0131s\u0131ndan \u00e7o\u011funun, art\u0131k etkisi ge\u00e7ti\u011fi tahmin edilen \u00e7ift doz Sinovac a\u015f\u0131l\u0131 oldu\u011funu s\u00f6yl\u00fcyor:<\/p>\n

“47 hastan\u0131n 15\u2019i a\u015f\u0131s\u0131z, 29\u2019u \u00e7ift doz Sinovac a\u015f\u0131l\u0131, 3\u2019\u00fc ise tek doz BioNTech a\u015f\u0131 olmu\u015f. Yani, yo\u011fun bak\u0131mdaki hastalar\u0131n yar\u0131dan biraz fazlas\u0131 \u00e7ift doz Sinovac a\u015f\u0131l\u0131. \u00c7ift doz Sinovac a\u015f\u0131s\u0131n\u0131n koruma s\u00fcresi ge\u00e7ti.<\/p>\n

“\u00d6te yandan yo\u011fun bak\u0131mda 2 doz BioNTech, 3 doz Sinovac ya da 2 doz Sinovac\u2019tan sonra tek doz BioNTech olmu\u015f hi\u00e7bir hastam\u0131z yok. Bu bulgu \u00e7ok \u00f6nemli \u00e7\u00fcnk\u00fc a\u015f\u0131n\u0131n ne kadar etkili oldu\u011funu g\u00f6steriyor.\u201d<\/p>\n

Ankara\u2019da son haftalarda hasta say\u0131s\u0131n\u0131n giderek artt\u0131\u011f\u0131n\u0131 s\u00f6yleyen \u00dcnal, Ankara \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesi\u2019nde de yo\u011fun bak\u0131m yataklar\u0131n\u0131n yar\u0131s\u0131ndan fazlas\u0131n\u0131n Covid-19 hastalar\u0131 i\u00e7in ayr\u0131ld\u0131\u011f\u0131n\u0131 s\u00f6yl\u00fcyor:<\/p>\n

“A\u015f\u0131 kesinlikle etkili ama Delta varyant\u0131 geldikten sonra 2 doz Sinovac etkisiz olmaya ba\u015flad\u0131. Ama 3 doz Sinovac olmu\u015f hi\u00e7bir hastay\u0131 yat\u0131rmam\u0131\u015f olmam\u0131z da gayet anlaml\u0131.<\/p>\n

“2 doz BioNTech\u2019in koruyuculu\u011fu da \u00e7ok net olarak ortada. T\u00fcrkiye\u2019deki varyant Delta diyoruz ama her ne varyant ise bu \u015fekilde a\u015f\u0131lama son derece etkili.”<\/p>\n

Sadece Ankara\u2019da de\u011fil t\u00fcm T\u00fcrkiye genelinde vaka say\u0131lar\u0131n\u0131n y\u00fckseli\u015fte oldu\u011funu s\u00f6yleyen \u00dcnal\u2019a g\u00f6re yo\u011fun bak\u0131mlardaki a\u015f\u0131l\u0131\/a\u015f\u0131s\u0131z hasta oran\u0131, kentlerin genel a\u015f\u0131lanma oran\u0131yla da ilgili:<\/p>\n

“Ankara a\u015f\u0131laman\u0131n nispeten y\u00fcksek oldu\u011fu bir \u015fehir. Dolay\u0131s\u0131yla bu \u015fehirde 3. dozlar\u0131n\u0131 yapt\u0131rmam\u0131\u015f, \u00e7ift doz Sinovac a\u015f\u0131l\u0131 yo\u011fun bak\u0131m hastalar\u0131 daha fazla var. Ama a\u015f\u0131laman\u0131n d\u00fc\u015f\u00fck oldu\u011fu \u015fehirlere gitti\u011finizde, yo\u011fun bak\u0131mlarda a\u015f\u0131s\u0131z olanlar\u0131n say\u0131s\u0131 daha fazla olabilir.”<\/p>\n

“\u00c7\u0130FT DOZ SINOVAC 4 AYDAN SONRA A\u015eISIZ OLMAK G\u0130B\u0130”<\/strong><\/p>\n

Yo\u011fun bak\u0131m uzman\u0131 Prof. Dr. \u0130smail Cinel ise 11 A\u011fustos\u2019ta T\u00fcrkiye genelinde yakla\u015f\u0131k 1000 Covid-19 yo\u011fun bak\u0131m hastas\u0131 ile yapt\u0131\u011f\u0131 bir ara\u015ft\u0131rman\u0131n \u00f6n sonu\u00e7lar\u0131na g\u00f6re, yo\u011fun bak\u0131mlardaki hastalar\u0131n \u00e7o\u011funlu\u011funu ya tamamen a\u015f\u0131s\u0131zlar ya da 3. doz a\u015f\u0131 hakk\u0131 oldu\u011fu halde olmayanlar\u0131n olu\u015fturdu\u011funu s\u00f6yl\u00fcyor.<\/p>\n

Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 ve Etik Kurul onay\u0131yla y\u00fcr\u00fct\u00fclen ara\u015ft\u0131rman\u0131n nihai sonu\u00e7lar\u0131n\u0131n \u00f6n\u00fcm\u00fczdeki hafta yay\u0131mlanaca\u011f\u0131n\u0131 s\u00f6yleyen Cinel, vatanda\u015flar\u0131 a\u015f\u0131n\u0131n \u00f6nemine dair uyarmak i\u00e7in \u00e7al\u0131\u015fman\u0131n \u00f6n sonu\u00e7lar\u0131n\u0131 kamuoyu ile payla\u015ft\u0131klar\u0131n\u0131 \u015f\u00f6yle anlat\u0131yor:<\/p>\n

“\u015eu anda yo\u011fun bak\u0131mlarda her 10 hastan\u0131n 5-6\u2019s\u0131n\u0131 hi\u00e7 a\u015f\u0131 olmam\u0131\u015flar, 3-4\u2019\u00fcn\u00fc ise Ocak-\u015eubat-Mart ay\u0131nda iki doz Sinovac a\u015f\u0131s\u0131n\u0131 olmu\u015f hastalar olu\u015fturuyor. \u0130ki doz Sinovac a\u015f\u0131s\u0131n\u0131n \u00fczerinden 4 aydan fazla zaman ge\u00e7ti\u011fi i\u00e7in a\u015f\u0131n\u0131n koruyuculu\u011fu azalm\u0131\u015f.”<\/p>\n

“Sinovac inaktif a\u015f\u0131 i\u00e7in koruyuculuk s\u00fcresi 3-6 ay \u015feklinde a\u00e7\u0131klanm\u0131\u015ft\u0131. T\u00fcrkiye\u2019de 4 aydan sonra bu a\u015f\u0131 korumam\u0131\u015f ve sadece \u00e7ift doz Sinovac a\u015f\u0131 olanlar resmen, neredeyse y\u00fczde 40 oran\u0131nda yo\u011fun bak\u0131mlara d\u00fc\u015fm\u00fc\u015f durumda.<\/p>\n

Cinel, \u00f6zellikle Ocak-Mart aras\u0131nda \u00e7ift doz Sinovac a\u015f\u0131s\u0131 olmu\u015f ki\u015filerin mutlaka 3. doz a\u015f\u0131 olmalar\u0131 gerekti\u011fini ve ikinci dozun \u00fczerinden 4 aydan fazla zaman ge\u00e7en ki\u015filerin art\u0131k “a\u015f\u0131s\u0131z” konumunda oldu\u011funu belirtiyor.<\/p>\n

BioNTech a\u015f\u0131s\u0131n\u0131n 8-12 ay koruyuculuk s\u00fcresinin oldu\u011funu hat\u0131rlatan Cinel, 2 doz Biontech a\u015f\u0131 olmas\u0131na ra\u011fmen yo\u011fun bak\u0131ma d\u00fc\u015fen hasta oran\u0131n\u0131n “yok denecek kadar” az oldu\u011funu ifade ediyor:<\/p>\n

“mRNA a\u015f\u0131 T\u00fcrkiye\u2019ye Nisan ay\u0131nda geldi. Hen\u00fcz bunun \u00fczerinden 8 ay ge\u00e7medi\u011fi i\u00e7in, mRNA a\u015f\u0131lar\u0131n\u0131n T\u00fcrkiye\u2019de ka\u00e7 ay korudu\u011fuyla ilgili \u015fu an net bir \u015fey s\u00f6yleyemem.<\/p>\n

“Ama mevcut durumda, 1000 hasta aras\u0131nda 2 doz mRNA a\u015f\u0131s\u0131 olup yo\u011fun bak\u0131ma d\u00fc\u015fen belki 2-3 hasta var. Yani yok denecek kadar az. Ent\u00fcbe olan ise hi\u00e7 yok. mRNA a\u015f\u0131s\u0131 olsan\u0131z bile y\u00fczde 90 korudu\u011fu i\u00e7in y\u00fczde 10 yakalanabilirsiniz hastal\u0131\u011fa ama hafif ge\u00e7mesine yol a\u00e7\u0131yor.”<\/p>\n

“A\u015eI OLMAMI\u015e, 30 YA\u015eINDAK\u0130 B\u0130R HASTAMI KAYBETT\u0130M”<\/strong><\/p>\n

\u0130stanbul\u2019da bir \u00f6zel hastanede g\u00f6rev yapan Prof. Dr. B\u00fclent Tutluo\u011flu da yo\u011fun bak\u0131mlardaki hasta profiline dair benzer bir tablo \u00e7iziyor.<\/p>\n

Tutluo\u011flu, \u015fu anda tedavi etti\u011fi Covid-19 yo\u011fun bak\u0131m hastalar\u0131n\u0131n ya a\u015f\u0131s\u0131z ya da \u00e7ift doz Sinovac a\u015f\u0131l\u0131 hastalardan olu\u015ftu\u011funu s\u00f6yl\u00fcyor.<\/p>\n

\u00c7ift doz Sinovac a\u015f\u0131l\u0131 ki\u015filerin “\u00f6nemli risk alt\u0131nda” oldu\u011funu s\u00f6yleyen Tutluo\u011flu\u2019na g\u00f6re, \u00e7ift doz BioNTech olmas\u0131na ra\u011fmen Covid-19 hastas\u0131 olan ki\u015filerin genellikle ayakta tedavi edildi\u011fini aktar\u0131yor:<\/p>\n

\u201c\u00c7ift doz BioNTech ya da 2 doz Sinovac \u00fczerine tek doz BioNTech yapt\u0131rm\u0131\u015f hastalar yo\u011fun bak\u0131mlarda \u00e7ok az say\u0131da. \u00c7ift doz Sinovac a\u015f\u0131s\u0131n\u0131n \u00fczerinden zaman ge\u00e7ti\u011fi i\u00e7in art\u0131k koruyuculu\u011fun zay\u0131flad\u0131\u011f\u0131n\u0131 g\u00f6r\u00fcyoruz.\u201d<\/p>\n

2 doz BioNTech a\u015f\u0131s\u0131 olan ki\u015filerin de Delta varyant\u0131 ile enfekte oldu\u011funu aktaran Tutluo\u011flu, maske ve mesafe gibi tedbirlerin elden b\u0131rak\u0131lmamas\u0131 gerekti\u011fini vurguluyor.<\/p>\n

A\u015f\u0131s\u0131z hastalar aras\u0131nda gen\u00e7lerin a\u011f\u0131rl\u0131kta oldu\u011funu belirten Tutluo\u011flu, vir\u00fcs\u00fcn mutasyon ge\u00e7irmesi nedeniyle art\u0131k gen\u00e7lerin de risk alt\u0131nda oldu\u011funu ve mutlaka a\u015f\u0131 olmalar\u0131 gerekti\u011fini belirtiyor:<\/p>\n

“\u0130leri ya\u015f grubunun \u00f6nemli bir kesimi a\u015f\u0131l\u0131 oldu\u011fu i\u00e7in onlarda tutunmas\u0131 zorla\u015fan vir\u00fcs, b\u00fcnyesindeki mutasyonlarla gen\u00e7lerde de tutunabilir hale geldi. Dolay\u0131s\u0131yla bu mutasyonlar\u0131n sonucu art\u0131k \u2018Gen\u00e7ler bu hastal\u0131\u011f\u0131 \u00e7ok rahat ge\u00e7iriyor\u2019 d\u00fc\u015f\u00fcncemiz tamamen de\u011fi\u015fti. 10 g\u00fcn \u00f6nce a\u015f\u0131s\u0131z 30 ya\u015f\u0131ndaki bir hastam\u0131 kaybettim, hi\u00e7bir ek hastal\u0131\u011f\u0131 yoktu.”<\/p>\n

BBC T\u00fcrk\u00e7e\u2019ye konu\u015fan hekimler, a\u015f\u0131 kar\u015f\u0131tl\u0131\u011f\u0131 yapan uzmanl\u0131k d\u0131\u015f\u0131 ki\u015filerin toplum sa\u011fl\u0131\u011f\u0131n\u0131 ciddi \u00f6l\u00e7\u00fcde olumsuz etkiledi\u011fini d\u00fc\u015f\u00fcn\u00fcyor.<\/p>\n

Yakla\u015f\u0131k 1,5 y\u0131ld\u0131r \u00e7ok say\u0131da Covid-19 hastas\u0131na bakt\u0131\u011f\u0131n\u0131 s\u00f6yleyen Tutluo\u011flu, a\u015f\u0131lar\u0131 “pandemiden \u00e7\u0131k\u0131\u015f bileti” olarak de\u011ferlendiriyor:<\/p>\n

“Hayat\u0131nda bir tane bile Covid-19 hastas\u0131 g\u00f6rmeyen ki\u015filer, a\u015f\u0131lar\u0131n etkinli\u011fiyle ilgili bilim d\u0131\u015f\u0131 iddialarda bulunuyor. Halbuki bizim referans\u0131m\u0131z bilimsel \u00e7al\u0131\u015fmalar ve kendi tecr\u00fcbelerimizdir. Hatta kendi tecr\u00fcbelerimiz bilimsel ara\u015ft\u0131rmalar\u0131n da \u00f6n\u00fcnde gelir. Benim g\u00fcnl\u00fck prati\u011fim de bilimsel \u00e7al\u0131\u015fmalar\u0131n a\u015f\u0131yla ilgili ortaya koyduklar\u0131yla \u00f6rt\u00fc\u015f\u00fcyor.”<\/p>\n

“\u00d6L\u00dcM SAYILARI G\u0130DEREK ARTIYOR”<\/strong><\/p>\n

T\u00fcrkiye\u2019de son g\u00fcnlerde tekrar neredeyse salg\u0131n\u0131n en \u015fiddetli oldu\u011fu d\u00f6nemlerdeki gibi g\u00fcnde 200\u2019den fazla ki\u015fi koronavir\u00fcs\u00fcn neden oldu\u011fu Covid-19 hastal\u0131\u011f\u0131 sonucu hayat\u0131n\u0131 kaybediyor.<\/p>\n

BBC T\u00fcrk\u00e7e\u2019ye konu\u015fan hekimlere g\u00f6re bu veri, yo\u011fun bak\u0131mlarda artan doluluk ve vaka say\u0131lar\u0131ndaki art\u0131\u015ftan ba\u011f\u0131ms\u0131z de\u011fil.<\/p>\n

Prof. Tutluo\u011flu, “Hasta say\u0131s\u0131 art\u0131nca \u00f6l\u00fcm say\u0131lar\u0131 da art\u0131yor. \u015eu anda \u00f6zellikle a\u015f\u0131s\u0131zlarda, risk gruplar\u0131nda veya 2 dozda kalm\u0131\u015f yeterli a\u015f\u0131lama olmayan ki\u015filerde \u00f6l\u00fcmler \u00e7ok daha fazla oluyor” diyor.<\/p>\n

Prof. \u00dcnal ise \u00f6zellikle Do\u011fu ve G\u00fcney Do\u011fu illerinde yo\u011fun bak\u0131mlarda yer bulunamaz durumda oldu\u011funu ifade ederek, bu durumun \u00f6l\u00fcm say\u0131lar\u0131n\u0131 do\u011frudan etkiledi\u011fini \u015f\u00f6yle a\u00e7\u0131kl\u0131yor:<\/p>\n

“Temmuz ay\u0131ndan itibaren vaka say\u0131lar\u0131 artmaya ba\u015flad\u0131. O art\u0131\u015flara paralel olarak yo\u011fun bak\u0131ma giri\u015fler artmaya ba\u015flad\u0131 ve \u00f6l\u00fcm say\u0131lar\u0131 da birbirini takip ederek art\u0131yor.”<\/p>\n

Kaynak: Reuters<\/p>\n","protected":false},"excerpt":{"rendered":"

<p>Sa\u011fl\u0131k Bakan\u0131 Fahrettin Koca son Bilim Kurulu toplant\u0131s\u0131 sonras\u0131 yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, koronavir\u00fcs\u00fcn neden oldu\u011fu Covid-19 hastal\u0131\u011f\u0131 nedeniyle hastaneye yatan ki\u015filerin y\u00fczde…<\/p>\n","protected":false},"author":2,"featured_media":11271,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-11270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/11270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=11270"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/11270\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/11271"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=11270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=11270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=11270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}